- ISIN
- US82024L1035
- CUSIP
- 82024L103
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Oct 9, 2020
Highlights
- Market Cap
- $588.11M
- Enterprise Value
- $499.73M
- EPS (TTM)
- -$0.59
- Total Revenue (TTM)
- $1.00M
- Gross Profit (TTM)
- -$835.00K
- EBITDA (TTM)
- -$48.60M
- Year Range
- $0.71 - $8.33
- Target Price
- $16.50
- ROA (TTM)
- -48.84%
- ROE (TTM)
- -52.04%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
STTK Performance Chart
Shattuck Labs, Inc. (STTK) is up 43.6% since the beginning of the year. At $5 per share, STTK is trading 37.1% below its 52-week high of $8. Investors who bought $1,000 worth of STTK shares 5 years ago would now be looking at an investment worth $186.
Loading charts...
Returns By Period
Shattuck Labs, Inc. (STTK) has returned 43.56% so far this year and 447.60% over the past 12 months.
Shattuck Labs, Inc.
- 1D
- 5.86%
- 1M
- -14.10%
- YTD
- 43.56%
- 6M
- 66.88%
- 1Y
- 447.60%
- 3Y*
- 16.78%
- 5Y*
- -28.54%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
STTK Monthly Returns History
Based on dividend-adjusted daily data since Oct 9, 2020, STTK's average daily return is +0.13%, while the average monthly return is +4.25%. At this rate, an investment would double in approximately 1.4 years.
Historically, 45% of months were positive and 55% were negative. The best month was Dec 2023 with a return of +263.8%, while the worst month was Oct 2024 at -63.9%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 5 months.
On a daily basis, STTK closed higher 47% of trading days. The best single day was Dec 13, 2023 with a return of +130.3%, while the worst single day was Oct 1, 2024 at -45.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 6.03% | 1.29% | 64.03% | 11.20% | -16.78% | -11.93% | 43.56% | ||||||
| 2025 | -4.13% | 13.79% | -28.02% | 4.09% | 2.12% | -21.60% | -3.81% | 28.78% | 143.68% | -19.67% | 9.38% | 73.81% | 201.65% |
| 2024 | 32.40% | -7.52% | 2.41% | 17.23% | -29.58% | -47.70% | 3.11% | -9.80% | -2.79% | -63.90% | -12.70% | 10.00% | -83.03% |
| 2023 | 81.30% | 13.19% | -37.71% | 2.04% | -7.67% | 12.64% | -18.27% | -15.29% | -29.63% | 6.58% | 20.99% | 263.78% | 210.00% |
| 2022 | -18.80% | -27.64% | -14.80% | -9.86% | -25.52% | 41.96% | -6.16% | -14.70% | -16.92% | -1.85% | -14.34% | 1.32% | -72.97% |
| 2021 | -5.34% | -16.75% | -29.20% | 28.86% | -27.97% | 6.82% | -23.97% | -4.13% | -3.55% | -5.30% | -56.06% | 0.35% | -83.76% |
Benchmark Metrics
Shattuck Labs, Inc. has an annualized alpha of 14.32%, beta of 1.27, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since October 09, 2020.
- This stock participated in 153.22% of S&P 500 Index downside but only 12.05% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 14.32%
- Beta
- 1.27
- R²
- 0.03
- Upside Capture
- 12.05%
- Downside Capture
- 153.22%
Return for Risk
Risk / Return Rank
STTK ranks 96 for risk / return — in the top 96% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Shattuck Labs, Inc. (STTK) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| STTK | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.37 | ||
| Sortino ratioReturn per unit of downside risk | +1.20 | ||
| Omega ratioGain probability vs. loss probability | 1.48 | 1.37 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 8.94 | 2.78 | +6.15 |
| Martin ratioReturn relative to average drawdown | 24.51 | 12.44 | +12.07 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Shattuck Labs, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Shattuck Labs, Inc. was 98.73%, occurring on Aug 1, 2025. The portfolio has not yet recovered.
The current Shattuck Labs, Inc. drawdown is 90.90%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 bear market2025 | -98.73%Aug 2025 | 4y 7mo | — | 5y 5moDec 2020 - now |
2020 correction2020 | -18.92%Nov 2020 | 5d | 2d | 7dNov 2020 - Nov 2020 |
2020 correction2020 | -18.09%Dec 2020 | 1d | 8d | 9dDec 2020 - Dec 2020 |
2020 correction2020 | -14.03%Oct 2020 | 3d | 14d | 17dOct 2020 - Oct 2020 |
2020 correction2020 | -13.19%Dec 2020 | 3d | 4d | 7dDec 2020 - Dec 2020 |
Drawdown Indicators
| STTK | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.73% | -56.78% | -41.95% |
Max Drawdown (1Y)Largest decline over 1 year | -50.51% | -9.10% | -41.41% |
Max Drawdown (3Y)Largest decline over 3 years | -93.45% | -18.90% | -74.55% |
Max Drawdown (5Y)Largest decline over 5 years | -97.47% | -25.43% | -72.04% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -90.90% | -1.80% | -89.10% |
Average DrawdownAverage peak-to-trough decline | -83.13% | -10.71% | -72.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.38% | 2.03% | +16.35% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Shattuck Labs, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Shattuck Labs, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for STTK relative to other companies in the Biotechnology industry. Currently, STTK has a P/S ratio of 444.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for STTK in comparison with other companies in the Biotechnology industry. Currently, STTK has a P/B value of 6.1. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with STTK
Add Shattuck Labs, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with STTK